Page last updated: 2024-08-24

sematilide and Ventricular Fibrillation

sematilide has been researched along with Ventricular Fibrillation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antimisiaris, M; Godfrey, R; Nademanee, K; Pacifico, A; Pruitt, C; Sager, PT; Singh, BN1
Blackburn, KJ; Burges, RA; Gwilt, M; Higgins, AJ; Milne, AA; Solca, AM1

Other Studies

2 other study(ies) available for sematilide and Ventricular Fibrillation

ArticleYear
Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Circulation, 1993, Volume: 88, Issue:3

    Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Syncope; Tachycardia, Ventricular; Ventricular Fibrillation

1993
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
    European journal of pharmacology, 1992, May-14, Volume: 215, Issue:2-3

    Topics: Action Potentials; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Heart; Heart Ventricles; Hemodynamics; Phenethylamines; Potassium Channels; Procainamide; Refractory Period, Electrophysiological; Sotalol; Sulfonamides; Ventricular Fibrillation

1992